Send feedback

PGAM2 p.Arg86Cys

c.256C>T · rs371509257 · VCV855880

Uncertain significance Multiple submitters
Classification
Uncertain significance
ClinVar
Review
Multiple submitters ★★☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.666 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.005%, amr)
Missense predictors
2/2 damaging
AlphaMissense, SaProt · REVEL no call
Conditions
1
glycogen storage disease due to phosphoglycerate mutase deficiency

Computational evidence

Protein change
AlphaMissense0.666likely pathogenic
REVEL0.579indeterminate
SaProtLLR -13.18damaging
⇒ AlphaMissense and SaProt both call this damaging; REVEL makes no call.
Splicing
SpliceAI—not assessed · no allele here is in the release
Constraint at this position
ConservationphyloP 12GERP 1.8, phastCons 1
Regional constrainto/e 0.98unconstrained · MANE · 2,762 bp · p 0.7 · regional, not allelic
Overall
CADD33.0PHRED · no single calibrated threshold — expert panels disagree

ClinVar classifies this uncertain; the computational predictors unanimously lean damaging — a triage signal, not a reclassification

AlphaMissense carries the ACMG weight for missense; REVEL and SaProt are independent agreement signals.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.005% Admixed American · 3/60,004 alleles
Filtering AF 0.00133% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.000668%
Overall 0.00335% 54/1,613,416 alleles · very rare
Ancestry group Frequency 1 in
Ashkenazi Jewishnot grpmax-eligible 0.101% 987
Remaining individualsnot grpmax-eligible 0.0112% 8,926
Admixed Americangrpmax 0.005% 20,001
European (non-Finnish) 0.0011% 90,773
South Asian 0.0011% 91,094

Ashkenazi Jewish shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
PGAM2
Protein
p.Arg86Cys
Coding
c.256C>T
MANE Select
NM_000290
dbSNP
rs371509257
Type
single nucleotide variant
Location
chr7:44065274 (GRCh38)
Gene constraint
LOEUF 1.421 · pLI <0.01 (gnomAD)
Structure
AlphaFold pLDDT 94.07
Full PGAM2 gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Disease context

glycogen storage disease due to phosphoglycerate mutase deficiency — disease report on Sugi Atlas → Associated genes, phenotypes, clinical trials & treatments

For Glycogen storage disease due to phosphoglycerate mutase deficiency (Orphanet):

Inheritance
Autosomal recessive
Onset
Adolescent, Childhood

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/pgam2-p-arg86cys (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown